Philip James Wealth Mangement, LLC Gilead Sciences, Inc. Transaction History
Philip James Wealth Mangement, LLC
- $857 Billion
- Q3 2025
A detailed history of Philip James Wealth Mangement, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Philip James Wealth Mangement, LLC holds 15,913 shares of GILD stock, worth $1.97 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
15,913
Previous 34,963
54.49%
Holding current value
$1.97 Million
Previous $3.88 Billion
54.43%
% of portfolio
0.21%
Previous 0.49%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
2,371Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...